Scarica l'app Stockscreener
0.2429
2.88%
-0.0072
Precedente Chiudi:
$0.2501
Aprire:
$0.251
Volume 24 ore:
606.40K
Relative Volume:
0.07
Capitalizzazione di mercato:
$4.74M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-0.0746
EPS:
-3.2558
Flusso di cassa netto:
-
1 W Prestazione:
-24.82%
1M Prestazione:
-13.96%
6M Prestazione:
-68.37%
1 anno Prestazione:
-80.87%
Intervallo 1D:
$0.2306
$0.2664
Intervallo di 1 settimana:
$0.2306
$0.325
Portata 52W:
$0.177
$1.60
Bionomics Ltd Adr Stock (BNOX) Company Profile
Nome
Bionomics Ltd Adr
Settore
Industria
Telefono
61 8 8150 7400
Indirizzo
200 GREENHILL ROAD, EASTWOOD SA
Confronta BNOX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNOX
Bionomics Ltd Adr
|
0.2429 | 4.74M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Bionomics Ltd Adr Stock (BNOX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Reiterato | Maxim Group | Buy |
| 2022-01-10 | Iniziato | Berenberg | Buy |
| 2022-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Iniziato | Evercore ISI | Outperform |
| 2022-01-10 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Bionomics Ltd Adr Borsa (BNOX) Ultime notizie
What Do Analysts Think About Bionomics Ltd. ADR’s (NASDAQ:BNOX) Future? - Stocks Register
Bionomics Reminds Shareholders to Cast their Vote for Re-Domiciliation from Australia to the United States - GlobeNewswire Inc.
United States shares higher at close of trade; Dow Jones Industrial Average up 3.56% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.88% - MSN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 3.55% - MSN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.89% - MSN
Bionomics announces shareholder meeting for US re-domiciliation - Investing.com India
Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement - GlobeNewswire
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 3.58% - MSN
United States shares higher at close of trade; Dow Jones Industrial Average up 0.89% - MSN
Why Bionomics (BNOX) Stock Is Up 100% Today - Benzinga
Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Bionomics secures AUS$1M milestone payment from Carina Biotech - Investing.com India
Bionomics secures AUS$1M milestone payment from Carina Biotech By Investing.com - Investing.com UK
Here’s Why DENTSPLY Sirona Inc (NASDAQ: XRAY) Is An Attractive Investment Right Now - Stocks Register
BNOX stock touches 52-week low at $0.23 amid sharp decline By Investing.com - Investing.com South Africa
BNOX stock touches 52-week low at $0.23 amid sharp decline - Investing.com India
Tonix Pharmaceuticals Holding Corp (TNXP): An Important Analyst Insights - Stocks Register
Sprinklr Inc (NYSE: CXM) Up 1.53%: This Is What Analysts Are Now Forecasting - Stocks Register
AgEagle Aerial Systems Inc. (AMEX: UAVS): Blank Check On Growth? - Stocks Register
BNOX stock touches 52-week low at $0.23 amid sharp annual decline - Investing.com Australia
Bionomics announces director resignation - Investing.com India
Bionomics announces director resignation By Investing.com - Investing.com UK
Analyzing Ratios: Bionomics Ltd. ADR (BNOX)’s Financial Story Unveiled - The Dwinnex
Apeiron entities sell Bionomics shares worth $82,526 - Investing.com
Apeiron entities sell Bionomics shares worth $82,526 By Investing.com - Investing.com South Africa
Bionomics commences phase 3 trial in anxiety disorder - Investing.com
BNOX stock touches 52-week low at $0.39 amid sharp annual decline - Investing.com
Bionomics plans U.S. re-domiciliation for strategic growth - Investing.com India
Bionomics plans U.S. re-domiciliation for strategic growth By Investing.com - Investing.com South Africa
Bionomics Ltd. ADR Inc. (BNOX) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Market Watch: Bionomics Ltd. ADR (BNOX)’s Noteworthy Drop, Closing at 0.64 - The Dwinnex
Bionomics Ltd. ADR (BNOX) stock analysis: A simple moving average approach - US Post News
Ratio Analysis: Unpacking Bionomics Ltd. ADR (BNOX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Is it possible to buy Bionomics Ltd. ADR(BNOX) shares at a good price now? - US Post News
Investor’s Toolkit: Key Ratios for Assessing Bionomics Ltd. ADR (BNOX)’s Performance - The Dwinnex
Recursion Pharmaceuticals Inc (RXRX) Has Recovered 32.29% From Its Low: Is This The Beginning Of A Trend? - Stocks Register
An analyst sees good growth prospects for Bionomics Ltd. ADR (BNOX) - SETE News
Bionomics Ltd. ADR [BNOX] Stock trading around $0.83 per share: What’s Next? - The DBT News
Bionomics Ltd. ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Bionomics to Provide a Corporate Update and Discuss - GlobeNewswire
Bionomics Ltd. ADR (BNOX) Stock: A Year of Decreases and Increases - The InvestChronicle
Nauticus Robotics Inc [KITT] Stock trading around $0.13 per share: What’s Next? - The DBT News
Chuy’s Holdings Inc [CHUY] fell -2.33% so far this year. What now? - The DBT News
Market cap of Kintara Therapeutics Inc [KTRA] reaches 15.16M – now what? - The DBT News
Bionomics Ltd. ADR Inc. (BNOX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Bionomics commences phase 3 trial for social anxiety treatment - Investing.com
Bionomics faces Nasdaq delisting over share price - Investing.com
Stock Market Recap: Bionomics Ltd. ADR (BNOX) Concludes at 0.69, a -2.76 Surge/Decline – DWinneX - The Dwinnex
Bionomics Ltd Adr Azioni (BNOX) Dati Finanziari
Non sono disponibili dati finanziari per Bionomics Ltd Adr (BNOX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):